Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial

NCT06818682 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.

NCT NCT06818682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06818682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial
Lead sponsor
Tata Memorial Centre
Phase
Phase 2
Overall status
Recruiting
Start date
February 17, 2025
Completion date
January 1, 2035
Enrollment
206 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate carcinoma